These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Cortical dysplasia as an epileptogenic focus: reduced binding of 123I-iomezanil with barely perceptible 99mTc-HMPAO SPECT]. Bartenstein P; Lehmenkühler C; Sciuk J; Schuierer G Nuklearmedizin; 1992 Aug; 31(4):142-4. PubMed ID: 1325635 [TBL] [Abstract][Full Text] [Related]
26. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 3)--Report on clinical usefulness in epilepsy]. Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K Kaku Igaku; 1996 Mar; 33(3):319-28. PubMed ID: 8622265 [TBL] [Abstract][Full Text] [Related]
27. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. Abi-Dargham A; Gandelman M; Zoghbi SS; Laruelle M; Baldwin RM; Randall P; Zea-Ponce Y; Charney DS; Hoffer PB; Innis RB J Nucl Med; 1995 Feb; 36(2):167-75. PubMed ID: 7830108 [TBL] [Abstract][Full Text] [Related]
28. Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors. Millet P; Graf C; Buck A; Walder B; Westera G; Broggini C; Arigoni M; Slosman D; Bouras C; Ibáñez V J Cereb Blood Flow Metab; 2000 Nov; 20(11):1587-603. PubMed ID: 11083234 [TBL] [Abstract][Full Text] [Related]
29. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model. Venz S; Hierholzer J; Cordes M; Straub HB; Keske U; Meencke HJ; Eichstädt H; Felix R Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750 [TBL] [Abstract][Full Text] [Related]
30. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments. Laruelle M; Baldwin RM; Rattner Z; al-Tikriti MS; Zea-Ponce Y; Zoghbi SS; Charney DS; Price JC; Frost JJ; Hoffer PB J Cereb Blood Flow Metab; 1994 May; 14(3):439-52. PubMed ID: 8163586 [TBL] [Abstract][Full Text] [Related]
31. Quantification of GABAA receptors in the rat brain with [(123)I]Iomazenil SPECT from factor analysis-denoised images. Tsartsalis S; Moulin-Sallanon M; Dumas N; Tournier BB; Ghezzi C; Charnay Y; Ginovart N; Millet P Nucl Med Biol; 2014 Feb; 41(2):186-95. PubMed ID: 24405841 [TBL] [Abstract][Full Text] [Related]
35. Advances in the pathophysiology of status epilepticus. Chen JW; Naylor DE; Wasterlain CG Acta Neurol Scand Suppl; 2007; 186():7-15. PubMed ID: 17784531 [TBL] [Abstract][Full Text] [Related]
36. The impact of diazepam's discovery on the treatment and understanding of status epilepticus. Goodkin HP; Kapur J Epilepsia; 2009 Sep; 50(9):2011-8. PubMed ID: 19674049 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy. Leroy C; Poisbeau P; Keller AF; Nehlig A J Physiol; 2004 Jun; 557(Pt 2):473-87. PubMed ID: 15034126 [TBL] [Abstract][Full Text] [Related]
38. [125I]iomazenil binding in the brains of spontaneously epileptic rats: an ex vivo quantitative autoradiographic study. Nagata T; Saji H; Nishizawa S; Yonekura Y; Yamamoto I; Iida Y; Magata Y; Konishi J; Serikawa T; Yokoyama A Nucl Med Biol; 1995 May; 22(4):445-9. PubMed ID: 7550020 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of benzodiazepine receptor in the cerebral cortex of Parkinson's disease using 123I-iomazenil SPECT]. Kawabata K; Tachibana H Nihon Rinsho; 1997 Jan; 55(1):244-8. PubMed ID: 9014458 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of neuronal loss in adult moyamoya disease by 123I-iomazenil SPECT. Sato S; Shirane R; Maruoka S; Yoshimoto T Surg Neurol; 1999 Feb; 51(2):158-63. PubMed ID: 10029420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]